‌

US Patent 10022359 1,9-diazaspiro undecane compounds having multimodal activity against pain

Patent 10022359 was granted and assigned to Esteve on July, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Esteve

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

100223590

Patent Inventor Names

Marina Virgili-Bernado0

Carlos Alegret-Molina0

Carmen Almansa-Rosales0

Date of Patent

July 17, 2018

Patent Application Number

155274580

Date Filed

November 20, 2015

Patent Primary Examiner

‌

Paul V Ward

Patent abstract

The present invention relates to compounds having dual pharmacological activity towards both the sigma (σ) receptor, and the μ-opiod receptor and more particularly to 1,9-diazaspiro undecane compounds having this pharmacological activity, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10022359 1,9-diazaspiro undecane compounds having multimodal activity against pain

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API